Osiris Therapeutics, Inc, Dundalk, MD. 2 likes. Local business.
- Identify new drug targets and therapeutic classes in the Osiris Therapeutics, Inc.'s R D portfolio and develop key strategic initiatives
The current gross profit margin for Osiris Therapeutics, Inc. as of Decem is % . Current and historical gross margin for Osiris Therapeutics, Inc. (OSIR) over the last 10 years. Stock Screener
Osiris Therapeutics, Inc.(OSIR) will be de-listed from the MIAX Options Exchange effective on Tuesday, Ma.
The hMSCs in Prochymal and Chondrogen products (Osiris Therapeutics, Inc, Baltimore, Maryland) were manufactured in a manner consistent with International
Osiris Therapeutics Inc operates within the pharmaceuticals and healthcare industry, specifically focusing on drug marketing authorization. It holds the
As of Ap, Osiris Therapeutics, Inc. operates as a subsidiary of Smith Nephew plc.
Osiris Therapeutics, Humacyte, Anteris Technologies, Biostage Luton - StemCells, Inc. (USA, but involved in global markets)
Previously held position. Osiris Therapeutics Inc. (March Feb. 2024), General Manager, Market Access and Reimbursement
Comments